Mindsai

Introducing MINDSAI: Revolutionizing Mental Healthcare Through Biomarker Innovation MINDSAI is pioneering the integration of biotechnology in mental healthcare, and we're excited to showcase two revolutionary products: Our Flagship Solutions- Minds.NAVI - The world's first depression screening solution combining salivary biomarkers with psychological assessment - 97.22% sensitivity - 95.24% specificity - Non-invasive, accessible technology CHEEU.Forest - Revolutionary VR-based digital therapeutic - 48% reduction in depressive symptoms - 54% reduction in suicide risk within 6 weeks - Clinically validated treatment approach Led by Expert Team- Dr. Seok Jeong-Ho (CEO)- Psychiatrist, Professor at Yonsei University College of Medicine - Dr. Jang Soo-Ah (Research Director)- Psychiatrist, Adjunct Professor at Yonsei University College of Medicine - Shin HyunKyung (Senior Researcher)- Clinical psychologist specializing in mental health diagnostics Visit Us at CES 2025! We invite you to experience our groundbreaking mental health solutions in person: Las Vegas Venetian Expo Booth #62817-25, Hall G(1F), Eureka Park January 7-10, 2025 Schedule a meeting with our team to discover how we're transforming mental healthcare! Learn more about our innovative solutions- CES Landing Page: https://mindsai.co.kr/ces - Schedule a Meeting: https://mindsai.co.kr/ces/reservation - Media Kit: https://bit.ly/3DHvQho Join us in transforming mental healthcare through cutting-edge technology and innovative diagnostics.#MentalHealth #HealthTech #Innovation #BioTechnology #CES2025 #Depression #DigitalHealth #Healthcare #MedTech #AI For inquiries: hkshin0716@mindsai.co.kr ahyunia@mindsai.co.kr